Withdrawal scales for - opioids

The COWS

The Clinical Opiate Withdrawal Scale (COWS) is a validated scoring tool assessing opioid withdrawal severity across observed and reported symptoms (pupil size, sweating, restlessness, GI symptoms, and others) - used both to guide symptom-triggered treatment and, importantly, to confirm adequate withdrawal severity before initiating buprenorphine (given its precipitated withdrawal risk if started too early)
Widely used in both acute withdrawal management settings and specifically in opioid agonist treatment induction, where confirming an adequate COWS score before the first buprenorphine dose is a standard, safety-relevant step

Opioid withdrawal reflects the physiological rebound of systems chronically suppressed by opioid receptor activation (autonomic hyperactivity, GI hypermotility, pain sensitisation) once opioid effect is removed - the COWS score's structured, multi-domain assessment captures this rebound syndrome's characteristic features more reliably than relying on patient-reported symptoms or a single sign alone

A minimum COWS score threshold (indicating the patient is already in mild-to-moderate withdrawal) should be confirmed before administering the first buprenorphine dose, given buprenorphine's partial-agonist mechanism and its potential to displace a still-active full opioid agonist from the receptor, precipitating a sudden, severe withdrawal reaction if given too early
Regular reassessment tracks withdrawal severity trajectory, both for general symptom management and specifically during buprenorphine induction to confirm the timing is appropriate

Symptomatic withdrawal management (non-opioid adjuncts for specific symptoms - e.g. antiemetics, antidiarrhoeals, alpha-2 agonists for autonomic symptoms) for patients not proceeding to opioid agonist treatment
Buprenorphine induction timed to an adequately elevated COWS score, avoiding precipitated withdrawal from premature administration
Methadone does not carry the same precipitated withdrawal risk as buprenorphine (being a full agonist) and can be started without waiting for the same withdrawal threshold, though its own dosing/titration safety considerations apply

Precipitated withdrawal risk with premature buprenorphine administration (a critical, frequently tested safety point), methadone vs buprenorphine induction timing difference, alpha-2 agonist (e.g. clonidine) use for symptomatic autonomic withdrawal management
Buprenorphine should only be given once the COWS score confirms the patient is already in at least mild-to-moderate withdrawal - giving it too early, while a full opioid agonist is still substantially active, risks precipitating a sudden and severe withdrawal reaction, since buprenorphine's high receptor affinity displaces the full agonist while providing only partial activation

4 more sections, plus exam facts

Premium unlocks every note across every specialty, and the full exam fact library behind it.